Aileron Therapeutics, Inc.

ALRN · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$12,865$17,313$5,194$3,600
Short-Term Investments$0$0$16,048$42,333
Receivables$0$0$0$0
Inventory$0$0$0$0
Other Curr. Assets$792$953$631$2,244
Total Curr. Assets$13,657$18,266$21,873$48,177
Property Plant & Equip (Net)$1$19$110$280
Goodwill$6,330$6,330$0$0
Intangibles$42,200$79,200$0$0
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$2$2,193$24$24
Total NC Assets$48,533$87,742$134$304
Other Assets$0$0$0$0
Total Assets$62,190$106,008$22,007$48,481
Liabilities
Payables$911$1,190$1,720$1,210
Short-Term Debt$0$48$66$93
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$4,838$3,147$1,598$3,205
Total Curr. Liab.$5,749$4,385$3,384$4,508
LT Debt$0$0$0$69
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$1,772$3,326$0$0
Other NC Liab.$277$91,410$0$0
Total NC Liab.$2,049$94,736$1,753$69
Other Liabilities$0$0-$1,753$0
Cap. Leases$0$48$33$162
Total Liabilities$7,798$99,121$3,384$4,577
Equity
Pref Stock$45,005$0$0$0
Common Stock$108$91$91$91
Retained Earnings-$351,400-$288,517-$272,785-$245,456
AOCI-$18-$63-$48-$13
Other Equity$405,702$203,966$291,365$289,282
Total Equity$54,392$6,887$18,623$43,904
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$62,190$106,008$22,007$48,481
Net Debt-$12,865-$17,265-$5,128-$3,438
Aileron Therapeutics, Inc. (ALRN) Financial Statements & Key Stats | AlphaPilot